Cleared Traditional

K905504 - STAINING SYSTEM FOR PNEUMOCYSTIS CARINII

K905504 is an FDA 510(k) clearance for STAINING SYSTEM FOR PNEUMOCYSTIS CARINII, manufactured by Dako Corp.. The device is a Class 2 Microbiology device with product code LYF cleared through the Traditional 510(k) pathway after a 203-day FDA review.

K905504 · Dako Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
203d
Days
Class 2
Risk

K905504 is an FDA 510(k) clearance for the STAINING SYSTEM FOR PNEUMOCYSTIS CARINII. Classified as Pneumocystis Carinii (product code LYF), Class II - Special Controls.

Submitted by Dako Corp. (Carpinteria, US). The FDA issued a Cleared decision on June 28, 1991 after a review of 203 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Dako Corp. devices

FDA 510(k) Submission Details - K905504

510(k) Number K905504 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 1990
Decision Date June 28, 1991
Days to Decision 203 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d slower than avg
Panel avg: 102d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LYF Device Classification - Class 2, Special Controls

Product Code LYF Pneumocystis Carinii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LYF Pneumocystis Carinii

Devices cleared under the same product code (LYF) and FDA review panel - the closest regulatory comparables to K905504.
LIGHT DIAGNOSTICS PNEUMOCYSTIS CARINII DFA, MODEL 31965
K992252 · Chemicon Intl., Inc. · Aug 1999
MERIFLUOR TM PNEUMOCYSTIS MODIFICATION
K904400 · Meridian Diagnostics, Inc. · Oct 1990
FLUOROSLIDE PNEUMOCYSTIS CARINII (IFA) ASSAY
K884047 · Disease Detection International, Inc. · Mar 1989
MERIFLUOR(TM) PNEUMOCYSTIS
K881608 · Meridian Diagnostics, Inc. · Aug 1988